RESUMO
AIMS: (i) Evaluation of delayed time to blood culture extraction by the Sepsityper kit and impact of shipping pellets off-site for MALDI-TOF MS analysis. (ii) Comparison of Sepsityper and laboratory-developed extraction methods from a literature review. METHODS AND RESULTS: Using two blood culture systems (BD BACTEC and VersaTREK), we extracted 411 positive blood cultures using the Sepsityper kit to mimic a potential protocol for institutions without a MALDI-TOF MS. Extracted pellets were shipped and analysed on the Bruker UltraflexIII. Successful extraction of 358 (87·1%) samples was determined by the presence of detectable proteins. MALDI-TOF MS correctly identified 332 (80·8%) samples. CONCLUSIONS: Delayed time to extraction did not affect Sepsityper extraction or MALDI-TOF MS accuracy. The extracted pellets remain stable and provide accurate results by MALDI-TOF MS when shipped at room temperature to off-site reference laboratories. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first study to show that institutions without a MALDI-TOF MS can take advantage of this innovative technology by shipping a volume of blood to an off-site laboratory for extraction and MALDI-TOF MS analysis. We also performed a literature review to compare various extraction methods.
Assuntos
Bactérias/isolamento & purificação , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Bacteriemia/diagnóstico , Proteínas de Bactérias/análise , Proteínas de Bactérias/isolamento & purificação , Técnicas Bacteriológicas/métodos , HumanosRESUMO
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has been found to be an accurate, rapid, and inexpensive method for the identification of bacteria and yeasts. Previous evaluations have compared the accuracy, time to identification, and costs of the MALDI-TOF MS method against standard identification systems or commercial panels. In this prospective study, we compared a protocol incorporating MALDI-TOF MS (MALDI protocol) with the current standard identification protocols (standard protocol) to determine the performance in actual practice using a specimen-based, bench-by-bench approach. The potential impact on time to identification (TTI) and costs had MALDI-TOF MS been the first-line identification method was quantitated. The MALDI protocol includes supplementary tests, notably for Streptococcus pneumoniae and Shigella, and indications for repeat MALDI-TOF MS attempts, often not measured in previous studies. A total of 952 isolates (824 bacterial isolates and 128 yeast isolates) recovered from 2,214 specimens were assessed using the MALDI protocol. Compared with standard protocols, the MALDI protocol provided identifications 1.45 days earlier on average (P < 0.001). In our laboratory, we anticipate that the incorporation of the MALDI protocol can reduce reagent and labor costs of identification by $102,424 or 56.9% within 12 months. The model included the fixed annual costs of the MALDI-TOF MS, such as the cost of protein standards and instrument maintenance, and the annual prevalence of organisms encountered in our laboratory. This comprehensive cost analysis model can be generalized to other moderate- to high-volume laboratories.
Assuntos
Bactérias/isolamento & purificação , Infecções Bacterianas/diagnóstico , Fungos/isolamento & purificação , Técnicas Microbiológicas/métodos , Técnicas de Diagnóstico Molecular/métodos , Micoses/diagnóstico , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Bactérias/química , Bactérias/classificação , Infecções Bacterianas/microbiologia , Análise Custo-Benefício , Fungos/química , Fungos/classificação , Humanos , Técnicas Microbiológicas/economia , Técnicas de Diagnóstico Molecular/economia , Micoses/microbiologia , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/economia , Fatores de TempoRESUMO
We have compared the location of the ocular tumors in hereditary retinoblastoma in relation to the age of the patients at time of diagnosis. Eighty fundus drawings were analyzed from 59 hereditary patients containing I 59 tumors. At the time of diagnosis, indirect ophthalmoscopy was performed under general anaesthesia in all patients and standard drawings of the retina were made depicting the number and relative location of all tumors. The distance between the center of the tumor and the center of the macula was measured and plotted against the age of the patients at time of diagnosis. The results show that the distance between the center of the tumor and the center of the macula at time of diagnosis increases with age during the first seven months after birth.
Assuntos
Retina/patologia , Neoplasias da Retina/patologia , Retinoblastoma/patologia , Pré-Escolar , Fundo de Olho , Humanos , Lactente , Recém-Nascido , Neoplasias da Retina/genética , Retinoblastoma/genética , Estudos RetrospectivosRESUMO
AIM: The aim of this study was to determine the (time trends in) incidence and survival of hereditary (familial and sporadic) and non-hereditary retinoblastoma for male and female patients born in the Netherlands between 1862 and 1995. METHOD: The national retinoblastoma register was updated and now consists of 955 patients. The missing dates of death were obtained from the municipal registers and the Central Bureau of Genealogy in The Hague. Mortality was compared with the Dutch vital statistics. RESULTS: From 1862 to 1995 no significant differences in incidence for retinoblastoma were found in the hereditary subgroups. Further, no significant differences between males and females were found, both overall and in the hereditary subgroups. The average incidence of retinoblastoma increased until 1944, probably due to incompleteness of the register, and stabilised after 1945 (1 per 17000 live births). From 1900 to 1995 the standardised mortality ratio increased for hereditary retinoblastoma patients from 2.9 to 9.0 and decreased for non-hereditary retinoblastoma patients from 1.9 to 1.0. CONCLUSION: Although survival for retinoblastoma was significantly better after 1945 than before, in comparison with the Dutch population the mortality between 1900 and 1990 increased for the hereditary and decreased for the non-hereditary retinoblastoma patients.
Assuntos
Neoplasias Oculares/epidemiologia , Retinoblastoma/epidemiologia , Neoplasias Oculares/mortalidade , Feminino , Humanos , Incidência , Modelos Lineares , Masculino , Países Baixos/epidemiologia , Sistema de Registros/estatística & dados numéricos , Retinoblastoma/genética , Retinoblastoma/mortalidade , Distribuição por Sexo , Taxa de Sobrevida/tendênciasRESUMO
PURPOSE: The aim of this survey was to review the different studies regarding the occurrence of second primary tumours (SPT) among survivors of retinoblastoma. METHODS: Ovid (Medline, Current contents life, Psychlit, Embase) was searched for the years 1966-1995 using the mesh headings: 'retinoblastoma', 'second primary neoplasms', and 'multiple primary neoplasms'. The inclusion criteria were: the study should involve 50 patients or more and should not be limited to one specific SPT. A checklist with criteria regarding the study design and the results was applied to each study. RESULTS: Eleven studies were identified which met the inclusion criteria. Thirty-five different types of SPT (Ntotal = 243) were reported. Most of them were osteosarcomas (37.0%), followed by melanomas (7.4%), soft-tissue sarcomas (6.9%), brain tumors (4.5%), fibrosarcomas (3.3%), chondrosarcomas (3.3%), and sarcomas (3.3%). Less frequently reported were leukemias (2:4%), sebaceous cell carcinomas (1.6%), and non-Hodgkin lymphomas (1.6%). Pineoblastoma, which in fact is a trilateral retinoblastoma and not an SPT, was found in 2.4%. Despite the differences, all 11 studies showed a higher incidence of SPT compared to the general population. Only 4 studies were judged to be free from selection bias, reporting a cumulative incidence of SPT of 8.4% 18 years after diagnosis, 15.7% at the age of 20 years, 19% at the age of 35 years, and a relative risk of 15.4 for SPT, respectively. CONCLUSION: SPT is a serious problem for the survivors of hereditary retinoblastoma and its importance should be recognized in (genetic) counseling of patients.
Assuntos
Neoplasias Oculares/epidemiologia , Segunda Neoplasia Primária/epidemiologia , Retinoblastoma/epidemiologia , Adolescente , Adulto , Neoplasias Ósseas/diagnóstico , Neoplasias Ósseas/epidemiologia , Neoplasias Ósseas/genética , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/epidemiologia , Neoplasias Encefálicas/genética , Criança , Pré-Escolar , Neoplasias Oculares/diagnóstico , Neoplasias Oculares/genética , Seguimentos , Humanos , Incidência , Lactente , Melanoma/diagnóstico , Melanoma/epidemiologia , Melanoma/genética , Segunda Neoplasia Primária/diagnóstico , Segunda Neoplasia Primária/genética , Glândula Pineal , Pinealoma/diagnóstico , Pinealoma/epidemiologia , Pinealoma/genética , Retinoblastoma/diagnóstico , Retinoblastoma/genética , Estudos Retrospectivos , Fatores de Risco , Sarcoma/diagnóstico , Sarcoma/epidemiologia , Sarcoma/genética , Neoplasias de Tecidos Moles/diagnóstico , Neoplasias de Tecidos Moles/epidemiologia , Neoplasias de Tecidos Moles/genética , Taxa de SobrevidaAssuntos
Neoplasias Oculares/radioterapia , Olho/efeitos da radiação , Radioterapia de Alta Energia/métodos , Retinoblastoma/radioterapia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Pré-Escolar , Crioterapia/métodos , Relação Dose-Resposta à Radiação , Enucleação Ocular , Neoplasias Oculares/tratamento farmacológico , Neoplasias Oculares/cirurgia , Feminino , Seguimentos , Humanos , Lactente , Recém-Nascido , Fotocoagulação a Laser/métodos , Masculino , Recidiva Local de Neoplasia , Lesões por Radiação/etiologia , Lesões por Radiação/cirurgia , Planejamento da Radioterapia Assistida por Computador , Radioterapia de Alta Energia/efeitos adversos , Reoperação , Retinoblastoma/tratamento farmacológico , Retinoblastoma/cirurgia , Estudos Retrospectivos , Taxa de Sobrevida , Resultado do Tratamento , Acuidade VisualRESUMO
We studied the appearance of retinoblastoma on unenhanced and gadolinium-enhanced images and the accuracy of tumour staging with MR imaging. The MR images were obtained in 18 children with retinoblastoma and compared with histopathological findings after enucleation. The MR imaging included T1-weighted and dual-echo T2-weighted images before, and T1-weighted images after, gadopentetate dimeglumine injection. The contrast between tumour and ipsilateral vitreous strongly increased (57 %) after gadolinium on T1-weighted images (p = 0.004). Tumour was strongly hypointense as compared with ipsilateral vitreous in all patients using heavily T2-weighted (TE = 120 ms) images (p = 0.001). The estimated T2 of tumour (mean 96 + 14 ms) did not correlate with histological grading or degree of calcification. Unenhanced T1-weighted MR images rightfully excluded extrascleral growth in 16 of 16 cases, but its presence was confirmed after enucleation in only one of 2 abnormal MR scans. Invasion of the optic nerve behind the cribriform plate was confirmed in 2 of 3 abnormal gadolinium-enhanced MR scans, but also in 1 of the 15 cases in which MR images were normal. The T2-weighted images were useful in assessing retinal detachment. We conclude that heavily T2-weighted images, unenhanced T1-weighted images and gadolinium-enhanced T1-weighted MR images are complementary in characterizing and staging retinoblastoma.
Assuntos
Neoplasias Oculares/diagnóstico , Imageamento por Ressonância Magnética/métodos , Retinoblastoma/diagnóstico , Meios de Contraste , Combinação de Medicamentos , Olho/patologia , Enucleação Ocular , Neoplasias Oculares/patologia , Neoplasias Oculares/cirurgia , Gadolínio , Gadolínio DTPA , Humanos , Lactente , Meglumina , Estadiamento de Neoplasias , Compostos Organometálicos , Ácido Pentético/análogos & derivados , Cuidados Pré-Operatórios , Retinoblastoma/patologia , Retinoblastoma/cirurgiaRESUMO
The purpose of this retrospective study is to investigate the influence of 45 Gy megavoltage external beam radiotherapy on the occurrence of second primary tumours in hereditary- and non-hereditary retinoblastoma patients. Eighty-seven hereditary and 19 non-hereditary patients were irradiated for retinoblastoma. The follow-up of the hereditary patients ranged from 4-23 years (mean 12.4 years), of the non-hereditary patients from 6-23 years (mean 12 years). In the hereditary group 4 patients developed a second primary tumour (2 rhabdomyosarcoma, 1 osteosarcoma, 1 malignant histiocytoma), and 5 patients developed a pineoblastoma. Three second primary tumours were situated inside the radiation field. The latency period ranged from 1.5 to 18 years (mean 4.8 years). None of the non-hereditary patients developed a second primary tumour. The actuarially calculated probability of being free from second primary tumours was 96.9% at 10 years and 89.4% at 20 years (pineoblastoma excluded). The survival was 91.2% at 10 years and 84.2% at 20 years (pineoblastoma excluded). From this study it is suggested that external beam irradiation has a potentiating effect in patients, with the genetic predispopsition for retinoblastoma and who are more susceptible to second primary malignancies.
Assuntos
Segunda Neoplasia Primária/etiologia , Neoplasias da Retina/genética , Neoplasias da Retina/radioterapia , Retinoblastoma/genética , Retinoblastoma/radioterapia , Adolescente , Adulto , Criança , Pré-Escolar , Seguimentos , Humanos , Incidência , Imageamento por Ressonância Magnética , Segunda Neoplasia Primária/patologia , Dosagem Radioterapêutica , Radioterapia de Alta Energia , Neoplasias da Retina/diagnóstico , Retinoblastoma/diagnóstico , Estudos Retrospectivos , Tomografia Computadorizada por Raios XRESUMO
The diagnosis of phaeochromocytoma can be extremely difficult with 40%-76% of cases escaping diagnosis during life. Until recently, the only available biochemical test for the detection of phaeochromocytoma in Singapore has been the 24-hour urinary vanillyl mandelic acid (VMA). Urinary VMA has been reported to have a high specificity (85%-100%) but variable sensitivity (28%-90%) in the diagnosis of this disease. In 1993, high performance liquid chromatography (HPLC) assays for the measurement of urinary catecholamines and metanephrines were introduced at the Singapore General Hospital. Since 1993, 4 cases of phaeochromocytoma have been detected at our institution. We report here, the diverse clinical presentations of these patients. The urinary-free catecholamine and catecholamine metabolite levels of these patients were compared with corresponding levels from 12 non-phaeochromocytoma patients. Using the reference value of 65.6 mumol/day, we found the urinary VMA to be a highly sensitive (100%) test with a specificity of only 31%. In contrast, a urinary total metanephrine level > or = 9,000 nmol/day was both sensitive (100%) as well as specific (100%).
Assuntos
Neoplasias das Glândulas Suprarrenais/diagnóstico , Feocromocitoma/diagnóstico , Adulto , Idoso , Catecolaminas/urina , Cromatografia Líquida de Alta Pressão , Feminino , Humanos , Masculino , Metanefrina/urina , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Ácido Vanilmandélico/urinaAssuntos
Oftalmopatias Hereditárias/complicações , Deficiência Intelectual/epidemiologia , Neoplasias da Retina/genética , Retinoblastoma/genética , Pré-Escolar , Feminino , Humanos , Lactente , Deficiência Intelectual/etiologia , Masculino , Países Baixos/epidemiologia , Prevalência , Sistema de RegistrosRESUMO
Primary aldosteronism, though an uncommon cause of hypertension, causes significant morbidity, making it important to diagnose and treat this condition. Its evaluation requires complex and time consuming investigative procedures in order to confirm the diagnosis and to differentiate between the subtypes of aldosterone producing adenoma and idiopathic hyperaldosteronism. Often, the values of renin and aldosterone are equivocal, and the diagnosis of primary aldosteronism is in doubt. In this study, we examine the use of aldosterone to renin ratios in confirming the diagnosis of primary aldosteronism when the usual criteria of suppressed renin and elevated aldosterone are not met. We have found that an aldosterone to renin ratio of 50 has a 100% specificity and 92% sensitivity for detecting primary aldosteronism. Also, an aldosterone to renin ratio of > 2000 is suggestive of an aldosterone producing adenoma.
Assuntos
Aldosterona/sangue , Hiperaldosteronismo/diagnóstico , Renina/sangue , Adenoma Adrenocortical/complicações , Adulto , Idoso , Humanos , Hiperaldosteronismo/etiologia , Pessoa de Meia-Idade , Estudos Retrospectivos , Sensibilidade e EspecificidadeRESUMO
The histopathology of 61 eyes was studied with special attention to the morphology of the retina adjacent to the main tumour. Three retinal types were distinguished. Retina type 1 (RT-1, 28 specimens) contained a single tumour that was sharply demarcated from surrounding normal retina. In retina type 2 (RT-2, 29 specimens) large parts of the retina were affected and the main tumour mass gradually blended with the adjacent pathological retina. Retina type 3 (RT-3, four specimens) was characterised by a retina almost entirely affected by diffuse tumour growth. RT-1 correlated significantly with early enucleation (0-3 years) both in hereditary and non-hereditary cases. RT-2 was seen in eyes enucleated later (2-5 years). The progressing tumour may release growth factors in the intraocular space that stimulate the cells of the adjacent retina and lead to multiple new primary tumours in the adjacent retinal area. RT-3 was only present in non-hereditary cases with late enucleation (at 2-5 years). Hereditary retinoblastoma cases are usually detected early. Therefore in hereditary cases RT-1 is significantly more common than RT-2. In 25 eyes of the 44 patients with unilateral sporadic retinoblastoma, multifocal tumours of the retina were observed. Such cases should not mistakenly be classified as hereditary cases on the basis of the histological pattern of multifocality of the tumour process.
Assuntos
Retina/patologia , Retinoblastoma/genética , Retinoblastoma/patologia , Fatores Etários , Criança , Pré-Escolar , Enucleação Ocular , Neoplasias Oculares/genética , Neoplasias Oculares/patologia , Feminino , Humanos , Lactente , Masculino , Retinoblastoma/classificação , Proteína do Retinoblastoma/genéticaRESUMO
The aim of this register-based follow-up study was to evaluate the long-term cumulative incidence of second primary tumors (SPT) among survivors of hereditary retinoblastoma, with special interest for the incidence of pineoblastoma in retinoblastoma patients born after 1970. The Dutch Retinoblastoma Register was completed and updated: in the period 1945-1994, 639 retinoblastoma patients were registered. The vital status of each patient was obtained from the municipal registries and the Central Office of Genealogy. SPT were traced and histopathologically confirmed. Survival curves and cumulative incidence of SPT were calculated by the Kaplan-Meier method. The survival of patients with hereditary retinoblastoma was significantly shorter than that of patients with non-hereditary retinoblastoma. The cumulative incidence of SPT in hereditary patients was 3.7 and 17.7% at the ages of 10 and 35 years, respectively. Long-term follow-up revealed a high proportion of melanomas (7 melanomas out of 28 SPT). In the sub-cohort of the hereditary-retinoblastoma patient group born after 1970, the cumulative incidence of pineoblastomas at the age of 5 years was 9.3%. Our results suggest that patients with hereditary retinoblastoma should have careful follow-up, and procedures for diagnosing SPT and pineoblastomas at an early and potentially treatable stage should be developed.
Assuntos
Neoplasias Oculares/genética , Neoplasias Induzidas por Radiação/epidemiologia , Segunda Neoplasia Primária/epidemiologia , Retinoblastoma/genética , Adolescente , Adulto , Fatores Etários , Neoplasias Encefálicas/epidemiologia , Criança , Pré-Escolar , Neoplasias Oculares/mortalidade , Neoplasias Oculares/radioterapia , Feminino , Seguimentos , Registros Hospitalares , Humanos , Incidência , Lactente , Masculino , Segunda Neoplasia Primária/mortalidade , Países Baixos/epidemiologia , Pinealoma/epidemiologia , Radioterapia/efeitos adversos , Sistema de Registros , Retinoblastoma/mortalidade , Retinoblastoma/radioterapia , Taxa de Sobrevida , Fatores de TempoRESUMO
We wished to determine the influence of parental age at the birth of a retinoblastoma patient on the risk of sporadic hereditary retinoblastoma. The parental age at birth of 941 patients of the Dutch retinoblastoma register (1862-1994) was identified and compared between sporadic hereditary and nonhereditary patients. In a subcohort (1936-1994), a comparison was made with parental age at birth in the general population, as obtained from the Central Bureau of Statistics. Missing birth dates of the parents of retinoblastoma patients were traced with the help of the municipal registries and the Central Bureau of Genealogy. The mean paternal age was 10.7 months higher and the mean maternal age was 11.0 months higher in the sporadic hereditary retinoblastoma patients than in parents of nonhereditary patients. In the subcohort, the mean paternal and maternal ages of sporadic hereditary patients were also higher (12.4 and 11.5 months, respectively) than those of the general population. All differences were statistically significant. This study shows that a high parental age is associated with an enhanced risk of sporadic hereditary retinoblastoma.
Assuntos
Neoplasias Oculares/genética , Genes do Retinoblastoma , Idade Materna , Idade Paterna , Retinoblastoma/genética , Adulto , Estudos de Coortes , Neoplasias Oculares/epidemiologia , Feminino , Humanos , Masculino , Países Baixos/epidemiologia , Sistema de Registros/estatística & dados numéricos , Retinoblastoma/epidemiologia , RiscoRESUMO
PURPOSE: The late side effects of external beam irradiation in patients with retinoblastoma such as orbital bony growth retardation, are a serious problem in adolescence. Therefore, a quantitative study was performed to investigate the late effects of irradiation on orbital growth in patients with retinoblastoma. METHODS: The orbits of 68 patients with retinoblastoma, 52 bilateral and 16 unilateral, were divided into two treatment groups: radiotherapy alone, 77 orbits; and radiotherapy + enucleation, 43 orbits. Follow-up time was 12 to 240 months (mean, 95 months) in group 1 and 27 to 216 months (mean, 97 months) in group 2. These groups were subdivided further into age groups at which radiotherapy was given. The morphometric measurements of these groups were compared. RESULTS: The authors showed that irradiation causes a significant growth retardation when compared with the growth of nonirradiated orbits (P<0.001). They also demonstrated that radiotherapy in children younger than 6 months of age is more damaging to the orbital growth than at an older age (P<0.01). Finally, the authors showed that secondary enucleation does not have an additive growth-retarding effect. CONCLUSION: Orbital growth retardation in patients with retinoblastoma after radiotherapy is influenced mainly by the age at which irradiation is given and is defined at 6 months. Theoretically, it would be desirable to postpone irradiation in children until they are older than 6 months of age if possible. The irradiation effect on these orbits is not enhanced by enucleation.
Assuntos
Desenvolvimento Ósseo/efeitos da radiação , Neoplasias Oculares/radioterapia , Ossos Faciais/efeitos da radiação , Órbita/efeitos da radiação , Lesões por Radiação/etiologia , Radioterapia de Alta Energia/efeitos adversos , Retinoblastoma/radioterapia , Pré-Escolar , Terapia Combinada , Enucleação Ocular , Ossos Faciais/crescimento & desenvolvimento , Seguimentos , Humanos , Lactente , Recém-Nascido , Órbita/crescimento & desenvolvimentoRESUMO
Early detection of retinopathy of prematurity (ROP) in premature and very-low-birth-weight infants is crucial. In this retrospective study, 581 infants either with a birth weight below 1500 g or a gestational age of less than 32 weeks, or who did not fit these criteria but were judged to be at increased risk, were screened for ROP. ROP developed in 159 (27.4%). The incidence of ROP appeared to be inversely proportional to birth weight and gestational age. Infants with a birth weight below 750 g had a significantly higher risk of developing stage 3 and 4 ROP. The mean age at detection was 7.6 +/- 1.6 weeks. Nearly all of the ROP cases and all of the stage 3 and 4 cases were detected between the 5th and 10th week. Because screening should be focused on these vision-threatening stages, ophthalmic examinations should be concentrated in, but not limited to, the period between the 5th and the 10th postnatal week.
Assuntos
Guias como Assunto , Programas de Rastreamento , Retinopatia da Prematuridade/prevenção & controle , Peso ao Nascer , Feminino , Idade Gestacional , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Retinopatia da Prematuridade/epidemiologia , Estudos RetrospectivosRESUMO
In vivo relative corneal transmittance was estimated using Tan's [(1971) Vision in the ultraviolet, thesis, University of Utrecht, The Netherlands] data on scotopic spectral sensitivity in aphakic eyes. This was combined with in vitro corneal transmittance data and in vivo light scattering data to arrive at absolute data. All data combined, the following function (no age dependence is found) resulted: log(transmittance) = -0.016-c*lambda-4 (lambda = wavelength in nm, lambda > 310 nm). c = 85*10(8) nm4 for direct transmittance (acceptance angle of the order of 1 deg) and c = 21*10(8) nm4 for total transmittance (acceptance angle close to 180 deg).
Assuntos
Envelhecimento/fisiologia , Córnea/fisiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Humanos , Luz , Matemática , Pessoa de Meia-Idade , Modelos Biológicos , Espalhamento de Radiação , Espectrofotometria , Raios UltravioletaRESUMO
To evaluate the effectiveness of CT and MRI at 0.5 T in the diagnosis and staging of retinoblastoma, we studied 11 patients in whom retinoblastoma was clinically suspected. Nine of the eleven had surgically proven retinoblastoma; in the other two a diagnosis of Coats' disease was made. MRI was not as specific as CT for diagnosing retinoblastoma, due to its lack of sensitivity in detecting calcification; it did, however, have superior contrast resolution. On MRI, Coats' disease was reliably diagnosed and easily differentiated from retinoblastoma. Moreover, the greater ability of MRI to differentiate subretinal fluid from tumour also confers high accuracy in measuring tumour size. CT is still the study of choice in the diagnosis of retinoblastoma, but when MRI is available, it should be performed for better differentiation from lesions such as Coats' disease.